Healthcare Services

Cell Viability Assays Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cell Viability Assays Market Expected To Change Between 2026 And 2030?

The market size for cell viability assays has shown substantial growth in recent years. It is projected to expand from $1.73 billion in 2025 to $1.91 billion in 2026, at a compound annual growth rate (CAGR) of 10.5%. The expansion witnessed in the historic period stems from factors such as the broader scope of in vitro research activities, increased spending on pharmaceutical R&D, a rise in toxicology testing, the greater adoption of cell culture models, and the accessibility of standardized assay kits.

The cell viability assays market is projected to experience substantial expansion in the coming years, reaching a valuation of $2.72 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.3%. This anticipated growth during the forecast period is fueled by factors such as a heightened demand for high-throughput drug discovery methods, the increasing adoption of automated assay platforms, the ongoing expansion of personalized medicine research, a growing emphasis on miniaturizing assays, and the greater integration of imaging-based viability analysis. Key trends expected during this period involve the greater uptake of high-sensitivity viability assays, an increasing reliance on microplate-based detection systems, a surging need for multiparametric cell health analysis, the broadening of drug screening applications, and a reinforced commitment to developing reproducible assay protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Underlying Factors Are Accelerating The Growth Of The Cell Viability Assays Market?

The rising prevalence of cell-based therapeutics is anticipated to drive the expansion of the cell viability assay market in the future. These therapeutics involve interventions utilizing living cells for the purpose of mending or substituting impaired tissue, addressing illnesses, or re-establishing typical physiological activity. The development of cell-based therapeutics is spurred by breakthroughs in biotechnology, a rise in funding for regenerative medicine, wider acceptance and uptake of cell therapies, and enhancements in cell engineering and production techniques. Cell viability assays play a crucial role in cell-based therapeutics by guaranteeing the well-being, operational capacity, and security of therapeutic cells, consequently enhancing the effectiveness of treatment and quality assurance. For instance, in 2023, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Consequently, the expansion in cell-based therapeutics is accelerating the development of the cell viability assay market.

How Is The Cell Viability Assays Market Structured Across Different Segments?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Key Developments And Trends Are Impacting The Cell Viability Assays Market?

Leading companies in the cell viability assays market are creating advanced cell screening technologies to enhance precision and accelerate drug discovery. These cell screening technologies improve cell viability assays by enabling high-throughput, accurate, and swift assessment of cellular health and responses, thereby optimizing experimental conditions and advancing the creation of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, launched CellShepherd, an innovative platform designed for single-cell analysis. It employs exclusive nanowell glass arrays to miniaturize cell-based experiments for real-time observation. The autonomous system offers accurate cell dispensing, sterile co-culturing, and imaging capabilities using brightfield and fluorescent channels. Its AI-powered analysis ensures precise cell counting and tracking. This user-friendly platform addresses the growing demand for accurate single-cell research in biomedical and life science applications.

Which Major Players Dominate The Cell Viability Assays Market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Read the full cell viability assays market report here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Region Is Projected To Dominate The Cell Viability Assays Market During The Forecast Period?

North America was the largest region in the cell viability assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Viability Assays Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2026, By The Business Research Company

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Cell And Genes Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795